Biotech

All Articles

I &amp I biotech Triveni raises $115M for preclinical antibodies

.Triveni Bio has trapped $115 million in collection B funds to progress preclinical antibody plans d...

IGM pivots coming from cancer to autoimmune, agitating C-suite

.IGM Biosciences ended in 2013 laying off team and simplifying its own cancer cells pipeline. Now, t...

Shattuck axes CD47 plan over unstable efficacy records, lays off 40% of staff and sheds Ono work

.Shattuck Labs has actually pounded one more nail into the casket of CD47. After finding a "modest" ...

BioMarin goes Camping outdoors, striking RNA deal with biotech

.BioMarin is adding combustion to the R&ampD fire, blowing a match with CAMP4 Therapies for civil li...

Cash- strapped Gritstone begins seek important substitutes as cancer cells vaccine data underwhelm

.Gritstone bio has introduced financiers to look into "potential value-maximizing tactics" after its...

Kailera launches with $400M series A, 4 Chinese excessive weight medicines

.Kailera Rehabs has released into the significantly crowded excessive weight space along with a port...

Metsera teams up with Amneal to secure down GLP-1 supply

.Along with very early stage 1 records now out in bush, metabolic condition outfit Metsera is losing...

Rivus blog posts records to back up muscle-sparing weight problems medication claims

.Rivus Pharmaceuticals has actually introduced the records behind its own period 2 weight problems s...

BMS pays out $110M to form T-cell treatment treaty, helping Top get time to advance prioritized pipeline

.Bristol Myers Squibb is paying for Best Medicine $110 million ahead of time to build reagents for e...

Generate gains an additional $1B-plus Big Pharma relationship

.Novartis has tattooed an offer possibly worth more than $1 billion along with Flagship-founded Gene...